ORGANIC
LETTERS
2000
Vol. 2, No. 19
2987-2990
Approaches to the Fully Functionalized
DEF Ring System of Ristocetin A via
Highly Selective Ruthenium-Promoted
SNAr Reaction
Anthony J. Pearson* and Jung-Nyoung Heo
Department of Chemistry, Case Western ReserVe UniVersity, CleVeland, Ohio 44106
Received July 7, 2000
ABSTRACT
Ruthenium-promoted intramolecular SNAr reaction has allowed the construction of the fully functionalized 16-membered DEF macrocycle 4 of
ristocetin A that incorporates the required arylglycine and arylserine residues as the F and E ring, respectively.
Ristocetin A (1), a glycopeptide related to vancomycin (2),
is an antibiotic1 produced by the microorganism Nocardia
lurida (Figure 1). Vancomycin is currently in clinical use
and is well-known as the “antibiotic of last resort” in
hospitals. Ristocetin A was also clinically employed to treat
bacterial infections in the late 1950s, but undesirable side
effects led to its discontinuation. Teicoplanin (3) is a
potentially useful experimental drug. Recently, the increasing
incidence of vancomycin-resistant strains of infectious
bacteria,2 as well as the challenging molecular architecture
of these antibiotics, has evoked considerable interest in the
total synthesis of these compounds.
an additional 14-membered ring with biaryl ether connection
between amino acid residues F and G. Only recently have
total syntheses of vancomycin and its aglycon been
accomplished.4-6 Our own efforts have focused on construc-
(3) For reviews, see: (a) Nicolaou, K. C.; Boddy, C. N. C.; Bra¨se, S.;
Winssinger, N. Angew. Chem., Int. Ed. 1999, 38, 2096-2152. (b) Evans,
D. A.; DeVries, K. M. In Glycopeptide Antibiotics; Nagarajan, R., Ed.;
Marcel Dekker: New York, 1994; pp 63-104. (c) Rao, A. V. R.; Gurjar,
M. K.; Reddy, K. L.; Rao, A. S. Chem. ReV. 1995, 95, 2135-2167.
(4) (a) Evans, D. A.; Wood, M. R.; Trotter, B. W.; Richardson, T. I.;
Barrow, J. C.; Katz, J. L. Angew. Chem., Int. Ed. 1998, 37, 2700-2704.
(b) Evans, D. A.; Dinsmore, C. J.; Watson, P. S.; Wood, M. R.; Richardson,
T. I.; Trotter, B. W.; Katz, J. L. Angew. Chem., Int. Ed. 1998, 37, 2704-
2708. (c) For an earlier synthesis of the orienticin C aglycon, see: Evans,
D. A.; Dinsmore, C. J.; Ratz, A. M.; Evrard, D. A.; Barrow, J. C. J. Am.
Chem. Soc. 1997, 119, 3417-3418. Evans, D. A.; Barrow, J. C.; Watson,
P. S.; Ratz, A. M.; Dinsmore, C. J.; Evrard, D. A.; DeVries, K. M.; Ellman,
J. A.; Rychnovsky, S. D.; Lacour, J. J. Am. Chem. Soc. 1997, 119, 3419-
3420.
(5) (a) Nicolaou, K. C.; Natarajan, S.; Li, H.; Jain, N. F.; Hughes, R.;
Solomon, M. E.; Ramanjulu, J. M.; Boddy, C. N. C.; Takayanagi, M. Angew.
Chem., Int. Ed. 1998, 37, 2708-2714. (b) Nicolaou, K. C.; Jain, N. F.;
Natarajan, S.; Hughes, R.; Solomon, M. E.; Li, H.; Ramanjulu, J. M.;
Takayanagi, M.; Koumbis, A. E.; Bando, T. Angew. Chem., Int. Ed. 1998,
37, 2714-2716. (c) Nicolaou, K. C.; Takayanagi, M.; Jain, N. F.; Natarajan,
S.; Koumbis, A. E.; Bando, T.; Ramanjulu, J. M. Angew. Chem., Int. Ed.
1998, 37, 2717-2719.
Molecules of this group generally have a heptapeptide
backbone structure with embedded biaryl ether and biphenyl
linkages.3 Both ristocetin A and teicoplanin have structural
features that are similar to vancomycin, but they incorporate
(1) (a) Williams, D. H.; Bardsley, B. Angew. Chem., Int. Ed. 1999, 38,
1172-1193. (b) Williams, D. H. Acc. Chem. Res. 1984, 17, 364-369.
(2) (a) Walsh, C. T.; Fisher, S. L.; Park, I.-S.; Parhalad, M.; Wu, Z.
Chem. Biol. 1996, 3, 21. (b) Henry, C. M. Chem. Eng. News 2000, 78(10),
41-43, 46-58.
10.1021/ol000180h CCC: $19.00 © 2000 American Chemical Society
Published on Web 08/30/2000